Detalhe da pesquisa
1.
Mortality Risk of Inflammatory Bowel Disease: A Case-Control Study of New York State Death Records.
Dig Dis Sci;
2019 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30604370
2.
Shorter Disease Duration Is Associated With Higher Rates of Response to Vedolizumab in Patients With Crohn's Disease But Not Ulcerative Colitis.
Clin Gastroenterol Hepatol;
2019 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30625408
3.
Increasing Pediatricians' Awareness of the Association between Anal Skin Tags and Earlier Diagnosis of Crohn's Disease.
Inflamm Intest Dis;
3(1): 40-42, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30505841
4.
Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium.
Am J Gastroenterol;
2018 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30390030
5.
The Role of Cannabis in the Management of Inflammatory Bowel Disease: A Review of Clinical, Scientific, and Regulatory Information: Commissioned by the Crohn's and Colitis Foundation.
Inflamm Bowel Dis;
2018 Oct 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-30358848
6.
Escalation of Immunosuppressive Therapy for Inflammatory Bowel Disease Is Not Associated With Adverse Outcomes After Infection With Clostridium difficile.
Inflamm Bowel Dis;
2018 Oct 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30312400
7.
Retrospective Analysis of Safety of Vedolizumab in Patients With Inflammatory Bowel Diseases.
Clin Gastroenterol Hepatol;
2018 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30268561
8.
Management of iatrogenic perforation during colonoscopy in ulcerative colitis patients: a survey of gastroenterologists and colorectal surgeons.
Int J Colorectal Dis;
33(11): 1607-1616, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-29978362
9.
Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium.
Am J Gastroenterol;
113(9): 1345-1354, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29946178
10.
Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn's Disease.
Gastroenterology;
155(3): 687-695.e10, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29857091
11.
Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease.
Inflamm Bowel Dis;
24(11): 2461-2467, 2018 Oct 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29788240
12.
The Comb Sign in Crohn's Ileocolitis.
J Gen Intern Med;
33(5): 773, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29532298
13.
A rare endoscopic finding: severely ulcerated giant sigmoid diverticulum.
Gastrointest Endosc;
87(4): 1159-1160, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29102732
14.
Hepatic Masses in a Patient With Inflammatory Bowel Disease.
Gastroenterology;
154(8): e5-e6, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28899719
15.
Obesity/Bariatric Surgery and Crohn's Disease.
J Clin Gastroenterol;
52(1): 50-54, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-28489647
16.
Radiology Prep to the Rescue: Radiocontrast Enema After Failure of Oral Bowel Preparation for Patients with an Ileocolonic Fistula.
Am J Gastroenterol;
112(9): 1363, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28874860
17.
TNF-alpha antagonist induced lupus on three different agents.
Postgrad Med;
129(2): 304-306, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27748629
18.
The Real-World Effectiveness and Safety of Vedolizumab for Moderate-Severe Crohn's Disease: Results From the US VICTORY Consortium.
Am J Gastroenterol;
111(8): 1147-55, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27296941
19.
Internet Searches About Therapies Do Not Impact Willingness to Accept Prescribed Therapy in Inflammatory Bowel Disease Patients.
Dig Dis Sci;
61(4): 1013-20, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26660681
20.
Patient considerations in the management of ulcerative colitis - role of vedolizumab.
Ther Clin Risk Manag;
11: 1235-42, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26316768